3-(4-Methylphenyl)-1,2-oxazole-5-carboxylic acid, 95%, 100mg

2,5-Difluoro-4-difluoromethylpyridine, 98.0%, 1g

acteoside, with analyt. Documents, 20 mg, glass packaging

tert-Butyl 3-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate, 97%, 100mg

(S)-3-Hydroxypyrrolidine, 97.0%, 250mg

4-((6-Amino-1-butyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(pentyl)amino)-4-oxobutanoic acid, 100mg

4,4,5,5-Tetramethyl-2-(pyren-2-yl)-1,3,2-dioxaborolane, 98+%, 250mg

2,3-Dimethyl-n-(2,2,2-trifluoroethyl)aniline, 95%, 50mg

1-BENZHYDRYL-3-AMINOAZETIDINE, 97.0%, 5g

4-(4-phenyl-4H-1,2,4-triazol-3-yl)piperidine dihydrochloride, 95.0%, 500mg

3-CHLOROISOQUINOLINE-1-CARBOXYLIC ACID, 95%, 100mg

Sodium 2,3,5,6-tetrafluoro-4-sulfophenolate, 98%, 25g

(S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride, 95.0%, 100mg